Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;204(6):2505-2507.
doi: 10.1111/bjh.19480. Epub 2024 Apr 23.

Unplanned pregnancy in women with beta-thalassaemia treated with luspatercept

Eleonora Zaccheddu  1 , Antonietta Zappu  1 , Susanna Barella  1 , Maria Grazia Clemente  1 , Valeria Orecchia  1 , Maria Paola Pilia  1 , Simona Piras  1 , Carla Pitturru  1 , Manuel Scarano  2 , Raffaella Origa  1   2   3
Affiliations

Unplanned pregnancy in women with beta-thalassaemia treated with luspatercept

Eleonora Zaccheddu et al. Br J Haematol. 2024 Jun.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Sheth S, Taher AT, Coates TD. Management of luspatercept therapy in patients with transfusion‐dependent‐thalassaemia.pdf|My Library|Zotero. 2023 [cited 2024 Jan 21]. Available from: https://www.zotero.org/raffaella.origa/collections/5FBMCSD6/items/8DIER4...
    1. Delgado J, Voltz C, Stain M, Balkowiec‐Iskra E, Mueller B, Wernsperger J, et al. The European medicines agency review of Luspatercept for the treatment of adult patients with transfusion‐dependent anemia caused by low‐risk myelodysplastic syndromes with ring Sideroblasts or beta‐thalassemia. HemaSphere. 2021;5(8):e616.
    1. Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, et al. A phase 3 trial of luspatercept in patients with transfusion‐dependent β‐thalassemia. N Engl J Med. 2020;382(13):1219–1231.
    1. Reblozyl: Summary of Product Characteristics. Available from: https://www.ema.europa.eu/en/documents/product‐information/reblozyl‐epar...
    1. Forni GL, Gianesin B, Musallam KM, Longo F, Rosso R, Lisi R, et al. Overall and complication‐free survival in a large cohort of patients with β‐thalassemia major followed over 50 years. Am J Hematol. 2023;98(3):381–387.

MeSH terms

LinkOut - more resources